{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:41:09Z","timestamp":1790372469380,"version":"4.1.0"},"reference-count":193,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.lfs.2021.120152","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T20:02:06Z","timestamp":1637006526000},"page":"120152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Bile acids as regulatory molecules and potential targets in metabolic diseases"],"prefix":"10.1016","volume":"287","author":[{"given":"Ai-jin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-tian","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120152_bb0005","series-title":"Physiology, Bile Acids","author":"Chen","year":"2021"},{"key":"10.1016\/j.lfs.2021.120152_bb0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/er.2000-0035","article-title":"Bile acid regulation of gene expression: roles of nuclear hormone receptors","volume":"23","author":"Chiang","year":"2002","journal-title":"Endocrinol. Rev."},{"key":"10.1016\/j.lfs.2021.120152_bb0015","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.lfs.2021.120152_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.lfs.2021.120152_bb0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0040","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2021.120152_bb0045","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0050","doi-asserted-by":"crossref","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0055","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0060","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.lfs.2021.120152_bb0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4239\/wjd.v7.i13.260","article-title":"Role of bile acids in the regulation of the metabolic pathways","volume":"7","author":"Taoka","year":"2016","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.lfs.2021.120152_bb0070","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3389\/fphar.2018.01382","article-title":"Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndrome","volume":"9","author":"Ethanic","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.aca.2011.01.050","article-title":"Antifungal evaluation of cholic acid and its derivatives on Candida albicans by microcalorimetry and chemometrics","volume":"689","author":"Kong","year":"2011","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.lfs.2021.120152_bb0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120152_bb0085","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00415-019-09377-y","article-title":"Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults","volume":"266","author":"Mandia","year":"2019","journal-title":"J Neurol."},{"issue":"3","key":"10.1016\/j.lfs.2021.120152_bb0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MPG.0000000000001657","article-title":"Oral cholic acid is efficacious and well tolerated in patients with bile acid synthesis and Zellweger spectrum disorders","volume":"65","author":"Heubi","year":"2017","journal-title":"J Pediatr Gastr Nutr."},{"key":"10.1016\/j.lfs.2021.120152_bb0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jimd.12042","article-title":"The cholic acid extension study in zellweger spectrum disorders: results and implications for therapy","volume":"42","author":"Klouwer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.lfs.2021.120152_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001693","article-title":"Cholic acid to treat HSD3B7 and AKR1D1 deficiencies","volume":"65","author":"Jacquemin","year":"2017","journal-title":"J. Pediatr. Gastr. Nutr."},{"key":"10.1016\/j.lfs.2021.120152_bb0105","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-016-9962-9","article-title":"Cholic acid therapy in zellweger spectrum disorders","volume":"39","author":"Berendse","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.lfs.2021.120152_bb0110","first-page":"41","article-title":"Clinical value of determining serum levels of glycocholic acid in alcoholic lesions of the liver","volume":"70","author":"Bocharova","year":"1992","journal-title":"Klin Med (Mosk)."},{"key":"10.1016\/j.lfs.2021.120152_bb0115","first-page":"79","article-title":"Clinical value of the determination of fasting glycocholic acid serum levels in patients with liver diseases. A comparison with standard liver tests","volume":"17","author":"Collazos","year":"1993","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.lfs.2021.120152_bb0120","article-title":"Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma","volume":"8","author":"Song","year":"2018","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.lfs.2021.120152_bb0125","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3892\/ol.2017.6763","article-title":"Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma","volume":"14","author":"Proungvitaya","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00231114","article-title":"Glycocholic acid in chronic active hepatitis and mild liver-diseases","volume":"72","author":"Collazos","year":"1993","journal-title":"Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120152_bb0135","article-title":"Glycocholic acid and butyrate synergistically increase vitamin D-induced calcium uptake in Caco-2 intestinal epithelial cell monolayers","volume":"13","author":"Casselbrant","year":"2020","journal-title":"Bone Rep."},{"key":"10.1016\/j.lfs.2021.120152_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0016-5085(80)90192-4","article-title":"Effects of taurocholic acid on gastric acid secretion and gastrin release","volume":"78","author":"Sekine","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.dld.2010.02.008","article-title":"Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats","volume":"42","author":"Glaser","year":"2010","journal-title":"Digest Liver Dis."},{"key":"10.1016\/j.lfs.2021.120152_bb0150","first-page":"942","article-title":"Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a Pl3K-mediated pathway","volume":"232","author":"Ueno","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0155","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.12659\/MSM.912429","article-title":"Improvement of glucose metabolism following long-term taurocholic acid gavage in a diabetic rat model","volume":"24","author":"Cheng","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.lfs.2021.120152_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0016-5085(80)90192-4","article-title":"Effects of taurocholic acid on gastric-acid secretion and gastrin-release","volume":"78","author":"Sekine","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120152_bb0170","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5694\/j.1326-5377.1980.tb135044.x","article-title":"Treatment of gallstones by chenodeoxycholic acid","volume":"1","author":"Toouli","year":"1980","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.lfs.2021.120152_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2019_226","article-title":"Chenodeoxycholic acid: an update on its therapeutic applications","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0180","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(74)91134-9","article-title":"Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia","volume":"2","author":"Miller","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.120152_bb0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2125.1978.tb01632.x","article-title":"Chenodeoxycholic acid therapy for hypertriglyceridaemia in men","volume":"5","author":"Bateson","year":"1978","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0190","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00223-012-9677-3","article-title":"Long-term bone density evaluation in cerebrotendinous xanthomatosis: evidence of improvement after chenodeoxycholic acid treatment","volume":"92","author":"Martini","year":"2013","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.lfs.2021.120152_bb0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-2944(75)90020-4","article-title":"Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous xanthomatosis","volume":"14","author":"Salen","year":"1975","journal-title":"Biochem Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410180418","article-title":"Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid","volume":"18","author":"Pedley","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.lfs.2021.120152_bb0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0016-5085(92)90855-S","article-title":"Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse","volume":"103","author":"Calmus","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/03009747509165448","article-title":"Effect of an intravenously administered bile acid (chenodeoxycholic acid) on rheumatoid arthritis","volume":"4","author":"Bruusgaard","year":"1975","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0215","series-title":"Human Microbiota in Health and Disease","first-page":"107","article-title":"Chapter 3 - gut microbiota influence lipid and glucose metabolism, energy homeostasis and inflammation through effects on bile acid metabolism","author":"Tungland","year":"2018"},{"key":"10.1016\/j.lfs.2021.120152_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(78)91780-4","article-title":"Chenodeoxycholic acid and diarrhoea","volume":"2","author":"Corazziari","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.120152_bb0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hep.1840020202","article-title":"A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis: the national cooperative gallstone study","volume":"2","author":"Fisher","year":"1982","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0306-9877(86)90137-4","article-title":"Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids","volume":"19","author":"Attili","year":"1986","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.lfs.2021.120152_bb0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/030006058301100211","article-title":"Treatment of constipation with chenodeoxycholic acid","volume":"11","author":"Bazzoli","year":"1983","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0240","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/apt.12999","article-title":"The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid","volume":"41","author":"Walters","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.120152_bb0245","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gutjnl-2013-305088","article-title":"Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo","volume":"63","author":"Mroz","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2021.120152_bb0250","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.toxlet.2006.06.006","article-title":"Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes","volume":"166","author":"Tsuchiya","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11010-008-0019-8","article-title":"The effect of capillarisin on glycochenodeoxycholic acid-induced apoptosis and heme oxygenase-1 in rat primary hepatocytes","volume":"325","author":"Lee","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2021.120152_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1007021710825","article-title":"Glycochenodeoxycholic acid (GCDC) induced hepatocyte apoptosis is associated with early modulation of intracellular PKC activity","volume":"207","author":"Gonzalez","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.lfs.2021.120152_bb0270","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.toxlet.2020.05.017","article-title":"Glycochenodeoxycholic acid impairs transcription factor E3-dependent autophagy-lysosome machinery by disrupting reactive oxygen species homeostasis in L02 cells","volume":"331","author":"Lan","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000071244","article-title":"Roles of reactive oxygen species, NF-kappaB, and peroxiredoxins in glycochenodeoxycholic acid-induced rat hepatocytes death","volume":"69","author":"Chu","year":"2003","journal-title":"Pharmacology"},{"key":"10.1016\/j.lfs.2021.120152_bb0285","first-page":"972","article-title":"Taurochenodeoxycholic acid induced biphasic hepatotoxicity in isolated perfused rat liver: roles of Ca2+ and calpain","volume":"50","author":"Hasegawa","year":"2003","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0290","doi-asserted-by":"crossref","first-page":"G88","DOI":"10.1152\/ajpgi.00450.2004","article-title":"Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers","volume":"289","author":"Rust","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24244513","article-title":"Taurochenodeoxycholic acid inhibited AP-1 activation via stimulating glucocorticoid receptor","volume":"24","author":"Li","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2021.120152_bb0300","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.intimp.2011.09.011","article-title":"Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats","volume":"11","author":"Liu","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2013.02.051","article-title":"Taurochenodeoxycholic acid induces apoptosis of fibroblast-like synoviocytes","volume":"706","author":"Li","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41390-018-0007-y","article-title":"Neonatal sepsis leads to early rise of rare serum bile acid tauro-omega-muricholic acid (TOMCA)","volume":"84","author":"Zohrer","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0315","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0039-128X(85)90006-6","article-title":"Metabolism of beta-muricholic acid in man","volume":"45","author":"Sacquet","year":"1985","journal-title":"Steroids"},{"key":"10.1016\/j.lfs.2021.120152_bb0320","doi-asserted-by":"crossref","first-page":"G494","DOI":"10.1152\/ajpgi.00156.2003","article-title":"Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse","volume":"285","author":"Wang","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0325","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1194\/jlr.M200297-JLR200","article-title":"Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L\/J mice","volume":"43","author":"Wang","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0330","first-page":"1","article-title":"Farnesoid X receptor signaling shapes the gut microbiota and controls hepatic lipid metabolism","author":"Zhang","year":"2016","journal-title":"mSystems"},{"key":"10.1016\/j.lfs.2021.120152_bb0335","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.120152_bb0340","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor Axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0345","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2012.07.029","article-title":"Tauro-beta-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential","volume":"424","author":"Denk","year":"2012","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.lfs.2021.120152_bb0350","first-page":"470","article-title":"Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content","volume":"17","author":"Ohiwa","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0355","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","article-title":"Mitochondrial control of cell death","volume":"6","author":"Kroemer","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0360","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.51.1.113","article-title":"Hepatoprotection with tauroursodeoxycholate and beta muricholate against taurolithocholate induced cholestasis: involvement of signal transduction pathways","volume":"51","author":"Milkiewicz","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2021.120152_bb0365","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/0016-5085(92)91727-L","article-title":"Tauro-Beta-muricholate preserves choleresis and prevents taurocholate-induced cholestasis in colchicine-treated rat-liver","volume":"102","author":"Katagiri","year":"1992","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lfs.2021.120152_bb0370","first-page":"S274","article-title":"Tauro-\u03b2-muricholic acid reduces glycochenodeoxycholic acid-induced apoptosis in a human hepatoma cell line by restoring the mitochondrial membrane potential","volume":"54","author":"GD","year":"2011","journal-title":"J. Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1872-034X.2007.00297.x","article-title":"Ursodeoxycholic acid: mechanism of action and novel clinical applications","volume":"38","author":"Ikegami","year":"2008","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0380","first-page":"145","article-title":"A practical review of primary biliary cholangitis for the gastroenterologist","volume":"15","author":"Onofrio","year":"2019","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.lfs.2021.120152_bb0385","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/bph.14705","article-title":"Ursodeoxycholic acid accelerates bile acid enterohepatic circulation","volume":"176","author":"Zhang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0390","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11745-017-4242-5","article-title":"Ursodeoxycholic acid suppresses lipogenesis in mouse liver: possible role of the decrease in beta-muricholic acid, a farnesoid X receptor antagonist","volume":"52","author":"Fujita","year":"2017","journal-title":"Lipids"},{"key":"10.1016\/j.lfs.2021.120152_bb0395","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.phrs.2018.08.008","article-title":"Effect of ursodeoxycholic acid on glycemic markers: a systematic review and meta-analysis of clinical trials","volume":"135","author":"Sanchez-Garcia","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0400","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0405","doi-asserted-by":"crossref","first-page":"G334","DOI":"10.1152\/ajpgi.00406.2015","article-title":"Ursodeoxycholic acid inhibits TNF alpha-induced IL-8 release from monocytes","volume":"311","author":"O'Dwyer","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver"},{"key":"10.1016\/j.lfs.2021.120152_bb0410","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0415","doi-asserted-by":"crossref","first-page":"G378","DOI":"10.1152\/ajpgi.00435.2016","article-title":"The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing","volume":"314","author":"Mroz","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0420","doi-asserted-by":"crossref","first-page":"48831","DOI":"10.1074\/jbc.M300468200","article-title":"Ursodeoxycholic acid modulates E2F\u20131 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes","volume":"278","author":"Sola","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120152_bb0425","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.gcb.2010.05.005","article-title":"Ursodeoxycholic acid and chemoprevention of colorectal cancer","volume":"34","author":"Serfaty","year":"2010","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.lfs.2021.120152_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040159","article-title":"Overview of bile acids signaling and perspective on the signal of ursodeoxycholic acid, the most hydrophilic bile acid, in the heart","volume":"8","author":"Hanafi","year":"2018","journal-title":"Biomolecules."},{"key":"10.1016\/j.lfs.2021.120152_bb0435","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.lfs.2021.120152_bb0440","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","article-title":"Bile acids: regulation of apoptosis by ursodeoxycholic acid","volume":"50","author":"Amaral","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0445","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1471-4159.2009.06429.x","article-title":"Bilirubin selectively inhibits cytochrome c oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid","volume":"112","author":"Vaz","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2021.120152_bb0450","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuro.2007.11.002","article-title":"Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid","volume":"29","author":"Brito","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.lfs.2021.120152_bb0455","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12035-014-8731-8","article-title":"Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration","volume":"51","author":"Vaz","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0460","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/nen.0b013e3181461c74","article-title":"Glycoursodeoxycholic acid and interleukin-10 modulate the reactivity of rat cortical astrocytes to unconjugated bilirubin","volume":"66","author":"Fernandes","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.lfs.2021.120152_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121471","article-title":"Tauroursodeoxycholate-bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives","volume":"8","author":"Kusaczuk","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.lfs.2021.120152_bb0470","article-title":"Anti-inflammatory effect of Tauroursodeoxycholic acid in RAW 264.7 macrophages, Bone marrow-derived macrophages, BV2 microglial cells, and spinal cord injury","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep-Uk."},{"key":"10.1016\/j.lfs.2021.120152_bb0475","first-page":"2218","article-title":"Mechanism of tauroursodeoxycholic acid-mediated neuronal protection after acute spinal cord injury through AKT signaling pathway in rats","volume":"13","author":"Dong","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.lfs.2021.120152_bb0480","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exer.2018.02.015","article-title":"Tauroursodeoxycholic acid binds to the G-protein site on light activated rhodopsin","volume":"170","author":"Lobysheva","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0485","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1046\/j.1471-4159.2000.0752368.x","article-title":"Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition","volume":"75","author":"Rodrigues","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2021.120152_bb0490","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"Schoemaker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0495","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4400560","article-title":"Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation","volume":"6","author":"Rodrigues","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2021.120152_bb0500","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2337\/db10-0308","article-title":"Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women","volume":"59","author":"Kars","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2021.120152_bb0505","doi-asserted-by":"crossref","first-page":"14876","DOI":"10.1038\/s41598-017-13974-0","article-title":"Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice","volume":"7","author":"Vettorazzi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.120152_bb0510","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2021.120152_bb0515","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/13543776.2016.1102888","article-title":"Formulations of deoxycholic for therapy: a patent review (2011\u20132014)","volume":"25","author":"Hwang","year":"2015","journal-title":"Expert Opin Ther Pat."},{"key":"10.1016\/j.lfs.2021.120152_bb0520","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0525","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10620-020-06208-3","article-title":"Deoxycholic acid-induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal inflammation","volume":"66","author":"Xu","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0530","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fimmu.2016.00536","article-title":"Deoxycholic acid triggers NLRP3 inflammasome activation and aggravates DSS-induced colitis in mice","volume":"7","author":"Zhao","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.120152_bb0535","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0016-5085(93)90967-H","article-title":"Different feedback-regulation of hepatic cholesterol and bile-acid synthesis by glycodeoxycholic acid in rabbits","volume":"105","author":"Xu","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0540","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11894-009-0057-8","article-title":"Bile acids in regulation of intestinal physiology","volume":"11","author":"Keating","year":"2009","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.lfs.2021.120152_bb0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0952-3278(95)90094-2","article-title":"Taurodeoxycholic acid stimulates rabbit gallbladder eicosanoid release","volume":"52","author":"Myers","year":"1995","journal-title":"Prostaglandins Leukot. Essent."},{"key":"10.1016\/j.lfs.2021.120152_bb0550","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1073\/pnas.051551698","article-title":"The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity","volume":"98","author":"Staudinger","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120152_bb0555","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mam.2017.04.002","article-title":"Bile acids and colon cancer: is FXR the solution of the conundrum?","volume":"56","author":"Gadaleta","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0560","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13287-016-0439-4","article-title":"Bile acid: a potential inducer of colon cancer stem cells","volume":"7","author":"Farhana","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.lfs.2021.120152_bb0565","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2009.08.030","article-title":"Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells","volume":"290","author":"Baek","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0570","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.24193","article-title":"Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice","volume":"53","author":"Matsubara","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0575","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxlet.2014.04.001","article-title":"Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice","volume":"228","author":"Woolbright","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0580","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI105432","article-title":"Production of bile duct hyperplasia and gallstones by lithocholic acid","volume":"45","author":"Palmer","year":"1966","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120152_bb0585","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.bbabio.2018.04.002","article-title":"Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness","volume":"1859","author":"Miko","year":"2018","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.lfs.2021.120152_bb0590","first-page":"11","article-title":"Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer","author":"Kovacs","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2021.120152_bb0595","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14456","article-title":"The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis","volume":"8","author":"Lajczak-McGinley","year":"2020","journal-title":"Physiol Rep."},{"key":"10.1016\/j.lfs.2021.120152_bb0600","doi-asserted-by":"crossref","first-page":"G550","DOI":"10.1152\/ajpgi.00256.2016","article-title":"Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon","volume":"312","author":"Ward","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0605","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxlet.2019.08.024","article-title":"The protective effect of lithocholic acid on the intestinal epithelial barrier is mediated by the vitamin D receptor via a SIRT1\/Nrf2 and NF-kappaB dependent mechanism in Caco-2 cells","volume":"316","author":"Yao","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.lfs.2021.120152_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176715","article-title":"Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the vitamin D receptor","volume":"12","author":"Pols","year":"2017","journal-title":"Plos One."},{"key":"10.1016\/j.lfs.2021.120152_bb0615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120152_bb0620","doi-asserted-by":"crossref","first-page":"17810","DOI":"10.1074\/jbc.M209898200","article-title":"Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets","volume":"278","author":"Beuers","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2021.120152_bb0625","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3892\/ijo.2015.2939","article-title":"Taurolithocholic acid promotes intrahepatic cholangiocarcinoma cell growth via muscarinic acetylcholine receptor and EGFR\/ERK1\/2 signaling pathway","volume":"46","author":"Amonyingcharoen","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2021.120152_bb0630","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fimmu.2012.00107","article-title":"Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer","volume":"3","author":"Rubin","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2021.120152_bb0635","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"issue":"659\u201370","key":"10.1016\/j.lfs.2021.120152_bb0640","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2021.120152_bb0645","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.15.3134","article-title":"Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease","volume":"15","author":"Gnewuch","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0650","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/nrdp.2016.14","article-title":"Irritable bowel syndrome","volume":"2","author":"Enck","year":"2016","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.lfs.2021.120152_bb0655","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.3748\/wjg.v20.i22.6759","article-title":"Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine","volume":"20","author":"Saha","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0660","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","article-title":"Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome","volume":"30","author":"Wedlake","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.120152_bb0665","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/S0016-5085(13)60536-3","article-title":"Quantitative assessment of fecal primary and secondary bile acids in health and irritable bowel syndrome (IBS) with diarrhea or constipation","volume":"144","author":"Shin","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0670","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.3748\/wjg.v26.i45.7153","article-title":"Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome","volume":"26","author":"Wei","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0675","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/nmo.12829","article-title":"Interplay between bile acid metabolism and microbiota in irritable bowel syndrome","volume":"28","author":"Dior","year":"2016","journal-title":"Neurogastroent Motil."},{"key":"10.1016\/j.lfs.2021.120152_bb0680","first-page":"600","article-title":"Managing the adult patient with short bowel syndrome","volume":"13","author":"Parrish","year":"2017","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"key":"10.1016\/j.lfs.2021.120152_bb0685","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/gut.35.8.1116","article-title":"Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism","volume":"35","author":"Akerlund","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2021.120152_bb0690","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jpen.1595","article-title":"Microbiome and metabolome profiles associated with different types of short bowel syndrome: implications for treatment","volume":"44","author":"Budinska","year":"2020","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.lfs.2021.120152_bb0695","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF02934085","article-title":"Disorder of bile acid metabolism in children with short bowel syndrome","volume":"32","author":"Ohkohchi","year":"1997","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120152_bb0700","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1477-3163.49014","article-title":"Colorectal carcinogenesis: review of human and experimental animal studies","volume":"8","author":"Tanaka","year":"2009","journal-title":"J Carcinog."},{"key":"10.1016\/j.lfs.2021.120152_bb0705","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.molmed.2011.05.010","article-title":"Bile acids and colon cancer: solving the puzzle with nuclear receptors","volume":"17","author":"Degirolamo","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0710","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00311772","article-title":"Is there a causal connection between bile acids and colorectal cancer?","volume":"26","author":"Tocchi","year":"1996","journal-title":"Surg. Today"},{"key":"10.1016\/j.lfs.2021.120152_bb0715","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0016-5085(93)90846-5","article-title":"Increased serum deoxycholic acid levels in men with colorectal adenomas","volume":"104","author":"Bayerdorffer","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120152_bb0720","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0959-8049(95)00216-6","article-title":"Role of bile acids in colorectal carcinogenesis","volume":"31A","author":"Nagengast","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lfs.2021.120152_bb0725","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0730","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury - what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0735","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2015.01.009","article-title":"Bile acid signaling and biliary functions","volume":"5","author":"Jones","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2021.120152_bb0740","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0745","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2021.120152_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105775","article-title":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","volume":"205","author":"Zhang","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.lfs.2021.120152_bb0755","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2021.120152_bb0760","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0765","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.15035","article-title":"Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD","volume":"49","author":"Caussy","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2021.120152_bb0770","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","article-title":"Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis","volume":"23","author":"Dasarathy","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0775","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2021.120152_bb0780","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1007\/s10620-015-3776-8","article-title":"Altered bile acid metabolome in patients with nonalcoholic steatohepatitis","volume":"60","author":"Ferslew","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0785","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2021.120152_bb0790","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0795","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2021.120152_bb0800","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.taap.2013.01.022","article-title":"Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease","volume":"268","author":"Lake","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"Plos One."},{"key":"10.1016\/j.lfs.2021.120152_bb0810","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1012812616083","article-title":"Beneficial effects of glycocholic acid (GCA) on gut mucosal damage in bile duct ligated rats","volume":"25","author":"Oktar","year":"2001","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2021.120152_bb0815","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12576-010-0117-8","article-title":"Experimental diabetes attenuates calcium mobilization and proliferative response in splenic lymphocytes from mice","volume":"61","author":"Satoh","year":"2011","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107974","article-title":"Taurocholic acid inhibits features of age-related macular degeneration in vitro","volume":"193","author":"Warden","year":"2020","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0825","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.intimp.2012.12.006","article-title":"Effects of taurocholic acid on immunoregulation in mice","volume":"15","author":"Wang","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2021.120152_bb0830","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM197309272891303","article-title":"Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones","volume":"289","author":"Thistle","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0835","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-95-3-257","article-title":"Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety","volume":"95","author":"Schoenfield","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0840","first-page":"3437","article-title":"Chenodeoxycholic acid treatment of gallstones: a survey of 25 patients (author's transl)","volume":"7","author":"Metreau","year":"1978","journal-title":"Nouv. Press. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0845","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF01308157","article-title":"Drug and treatment efficacy of chenodeoxycholic acid in 97 patients with cholelithiasis and increased surgical risk","volume":"28","author":"Tangedahl","year":"1983","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0850","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0002-9610(82)90128-3","article-title":"Interaction of chenodeoxycholic acid and dietary-cholesterol in the treatment of cholesterol gallstones","volume":"143","author":"Doty","year":"1982","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.lfs.2021.120152_bb0855","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.1840160317","article-title":"Differential-effects of chenodeoxycholic and ursodeoxycholic acids on Interleukin-1, Interleukin-6 and tumor-necrosis-factor-alpha production by monocytes","volume":"16","author":"Calmus","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2021.120152_bb0860","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","article-title":"The bile acid chenodeoxycholic acid increases human Brown adipose tissue activity","volume":"22","author":"Broeders","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2021.120152_bb0865","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123315","article-title":"Chenodeoxycholic acid from bile inhibits influenza a virus replication via blocking nuclear export of viral ribonucleoprotein complexes","volume":"23","author":"Luo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2021.120152_bb0870","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tox.2007.08.095","article-title":"Interaction between caspase-8 activation and endoplasmic reticulurn stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells","volume":"241","author":"Lizaka","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2021.120152_bb0875","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.sla.0000236631.72698.99","article-title":"Bile salts induce resistance to apoptosis through NF-kappaB-mediated XIAP expression","volume":"245","author":"Turner","year":"2007","journal-title":"Ann. Surg."},{"key":"10.1016\/j.lfs.2021.120152_bb0880","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1023\/B:DDAS.0000043383.96077.99","article-title":"Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NF-kappaB","volume":"49","author":"Toledo","year":"2004","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0885","first-page":"761","article-title":"The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice","volume":"26","author":"Zhou","year":"2013","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0890","first-page":"G1249","article-title":"Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation","volume":"272","author":"Uchida","year":"1997","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2021.120152_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147772","article-title":"Mice abundant in muricholic bile acids show resistance to dietary induced steatosis, weight gain, and to impaired glucose metabolism","volume":"11","author":"Bonde","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.lfs.2021.120152_bb0900","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.22627","article-title":"Ratio of conjugated chenodeoxycholic to muricholic acids is associated with severity of nonalcoholic steatohepatitis","volume":"27","author":"Chen","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.lfs.2021.120152_bb0905","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41374-020-00509-x","article-title":"Stress can attenuate hepatic lipid accumulation via elevation of hepatic beta-muricholic acid levels in mice with nonalcoholic steatohepatitis","volume":"101","author":"Takada","year":"2021","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2021.120152_bb0910","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/0024-3205(90)90486-B","article-title":"Tauro Beta-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver-damage in the rat","volume":"47","author":"Kanai","year":"1990","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2021.120152_bb0915","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1113\/jphysiol.2013.252544","article-title":"Ursodeoxycholic acid attenuates colonic epithelial secretory function","volume":"591","author":"Kelly","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.lfs.2021.120152_bb0920","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120152_bb0925","article-title":"Ursodeoxycholic acid attenuates the retinal vascular abnormalities in anti-PDGFR-beta antibody-induced pericyte depletion mouse models","volume":"10","author":"Shiraya","year":"2020","journal-title":"Sci Rep-UK."},{"key":"10.1016\/j.lfs.2021.120152_bb0930","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lfs.2021.120152_bb0935","doi-asserted-by":"crossref","first-page":"39838","DOI":"10.1038\/srep39838","article-title":"Tauroursodeoxycholic acid reduces ER stress by regulating of akt-dependent cellular prion protein","volume":"6","author":"Yoon","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.120152_bb0940","first-page":"4586","article-title":"Tauroursodeoxycholic acid inhibits endoplasmic reticulum stress, blocks mitochondrial permeability transition pore opening, and suppresses reperfusion injury through GSK-3ss in cardiac H9c2 cells","volume":"8","author":"Xie","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2021.120152_bb0945","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8090367","article-title":"Tauroursodeoxycholic acid protects retinal pigment epithelial cells from oxidative injury and endoplasmic reticulum stress in vitro","volume":"8","author":"Alhasani","year":"2020","journal-title":"Biomedicines."},{"key":"10.1016\/j.lfs.2021.120152_bb0950","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1471-4159.2004.02517.x","article-title":"Inhibition of the E2F\u20131\/p53\/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells","volume":"90","author":"Ramalho","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.lfs.2021.120152_bb0955","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1210\/me.2006-0063","article-title":"Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis","volume":"20","author":"Sola","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120152_bb0960","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1039\/C8FO01143E","article-title":"Deoxycholic acid disrupts the intestinal mucosal barrier and promotes intestinal tumorigenesis","volume":"9","author":"Liu","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.lfs.2021.120152_bb0965","doi-asserted-by":"crossref","first-page":"99","DOI":"10.18054\/pb.2016.118.2.3673","article-title":"Effect of conjugated bile salt taurodeoxycholic acid (TDCA) on mice colonic motor activity","volume":"118","author":"Abdu","year":"2016","journal-title":"Period Biol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:56:56Z","timestamp":1758401816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521011395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":193,"alternative-id":["S0024320521011395"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120152","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile acids as regulatory molecules and potential targets in metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120152"}}